Hosted by Access Infinity · 🇺🇸 US · EN-US · 32 episodes
Established thought leaders with verified media credentials.
Brought to you by the team at Access Infinity, this podcast shines a spotlight on the people in market access. In each episode we interview a different industry professional to discover their journey into market access, what inspires them and what they feel is on the horizon for this this ever-changing and exciting industry.
Access Infinity hosts Market Access Matters, a science show with 32 episodes published.
In this episode, we hear from Megan O'Brien, Associate Director at Access Infinity, to explore why understanding payer perception is so difficult to capture in a structured way. Megan shares how traditional KPIs like tim
Most Favored Nation (MFN) pricing has taken over conversations at conferences, client meetings, and boardrooms alike, but what does it actually mean in practice? In this episode, we continue the conversation on evolving
In this episode we sit down with Nikhil Taxak, Head of Pricing and Market Access Data Analytics at Access Infinity, to explore the rapidly evolving market access landscape. From the US Most Favored Nation (MFN) policy an
In this episode, we're joined by Louisa Oliver Byrne, Senior Consultant at Access Infinity. We learn about the complexities of the Most Favored Nation (MFN) policy and its implications for pharmaceutical market access. L
In this episode, we invite Access Infinity Partner, Isabel Rubio back to the podcast to explore the unique challenges and innovative solutions reshaping market access and pricing within rare disease. Isabel shares insigh
In this insightful episode we speak with Lizzie Shanahan, Global Access AI Strategy Lead at Sanofi. With over six years' experience at Sanofi and a rich background in commercial roles, Lizzie shares her unique journey in
In this episode, we speak with Silvy Mardiguian, Senior Director and Head of HEOR for Europe & New Markets at BeiGene. Silvy has been co-leading BeiGene’s preparedness and organisational readiness for the new Joint Clini
In this episode we chat with Jie Shen, who is Vice President Global Head Market Access at CSL. Having started her career in pharma before the market access function existed, Jie is an industry veteran. We cover the chang
We're kicking off 2025 with a fantastic podcast episode featuring Katrin Jack, Global Access Strategy Head at Galderma and President of the Healthcare Businesswomen's Association Zürich-Zug Chapter. This episode covers a
In this episode we speak with Ezgi Erdogan who is Oncology Market Access Director for Emerging Markets at GSK. In this discussion, we cover the unpredictability of emerging markets and the unique challenges this presents
In this episode, we sit down with Pauline Payen, Director and Global Payer Strategy Lead for UCB’s Early Portfolio. Pauline shares her pragmatic insights into navigating the complexities of global market access. Througho
In this episode we're joined by GSK's Head of Market Access for General Medicines, Rupert Gale. Rupert has been in pharma for over 27 years and is still going strong! In this discussion, he shares what resilience means t
Korinna Karampampa, who is Director Market Access and Pricing at CSL Behring, joins this episode to share her views on sustainable economic development. Korinna shares what led her into market access and explains what dr
In this episode we're joined by our first guest from Biotech - Ning Lu, who is Associate Director, International Pricing & Market Access at Blueprint Medicines. Ning shares her views on the complexities of market access
There’s no doubt that Market Access and Pricing leaders are fast becoming strategic partners in helping their wider organisations to understand the critical role of the function. In this episode, Marco Rauland from Merck
In this episode we're joined by Yvonne Hilsky who is Director of Market Access at Moderna. Having spent over 30 years in industry, Yvonne shares her views on what it takes to be successful in market access, including why
In this special episode which coincides with Disability Pride Month, we're joined by Senior Analyst Shubham Jadhav. Shubham has Becker Muscular Dystrophy (BMD) which is a form of muscular dystrophy and causes progressive
Sam is Head of Market Access Canada at Incyte Biosciences Canada and joins the podcast to discuss the evolving market access landscape in Canada. As part of his conversation with Louise, he describes the unique challenge
In this episode we're joined by Joao Carrasco, Director, Global Market Access Team at Bayer Pharmaceuticals. With a 12+ year career spanning both HEOR and Market Access functions, Joao shares his journey and how his stro
In this episode we look at market access through a different lens. We're joined by Becky Germino who has extensive experience in HEOR across a broad range of pharma organisations. Becky joined Sanofi this year as HEVA, N
Sponsor detection runs nightly. Check back soon.
No public pitch examples yet for this show.
Generate your own personalised pitchBased on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:
Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
Market Access Matters has a verified contact on file. Create a free PitchCentric account to access it and generate a personalised pitch in seconds. Research at least 3 recent episodes first and lead with a specific angle that serves their science audience.
Market Access Matters is hosted by Access Infinity. The show is categorised under science (life) and has published 32 episodes.
Market Access Matters has published 32 episodes.
Market Access Matters regularly covers science, life, technology. It sits in the science category, with a life focus.
Market Access Matters is accessible for guests with genuine science expertise. A personalised, episode-aware pitch will still outperform a generic one every time.
Market Access Matters hasn't explicitly signalled guest openness in recent episodes. That doesn't rule out pitching. your hook just needs to be especially compelling and relevant to their recent content.
Episodes of Market Access Matters average 24 minutes. a focused format where a clear narrative arc and tight preparation matter most.
Our data rates Market Access Matters's guest bar at 80/100 (Premium tier). Established thought leaders with verified media credentials. Sign in to PitchCentric to see how your own Pod Score compares against this show.
Methodology. Booking Probability™ blends Listen Score, 30-day Virality, open-to-guests detection, and Apple ratings. Data refreshed every 60 minutes. Listen Score and Booking Probability are calculated by PitchCentric. Last enriched today.